Predicting outcomes for patients with leukemia and MDS after COVID-19 infection

Identifying risk factors for severe COVID-19 in patients with AML, MDS and ALLПодробнее

Risks and outcomes of COVID-19 infection for patients on immunotherapyПодробнее

Responses to COVID-19 vaccines in patients with AML and MDSПодробнее

Responses to COVID-19 vaccination in patients with MDS and AMLПодробнее

COVID-19 risk factors in patients with hematologic malignanciesПодробнее

How does COVID-19 affect the outcomes of patients with AML?Подробнее

What AML Patients Should Know About the COVID-19 VaccinesПодробнее

Assessing COVID-19 infection rates in patients with AML and MPNПодробнее

CLL and COVID-19: patient outcomesПодробнее

Impact of COVID-19 on the management of MDSПодробнее

MRD Helps Predict Outcomes and Informs Transplant Decision for an ALL PatientПодробнее

The Effect of Covid-19 on AML TreatmentПодробнее

COVID-19 occurrence and impact in hematological oncology patientsПодробнее

Treating leukemia during the COVID-19 pandemicПодробнее

Managing AML Patients During COVID-19Подробнее

The effect of COVID-19 on CLL patient experiencesПодробнее

Predicting treatment outcomes in patients with r/r cHL with ctDNA and PETПодробнее

Improving Outcomes for Hospitalized Patients with COVID-19Подробнее

COVID-19 vaccination in MDS & AMLПодробнее